Day: September 21, 2021

London, UK, Sept. 21, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in two upcoming investor conferences as follows:            Maxim Group and M-Vest Mental Health Advances in Mental Health, Psychedelics and Non-Psychedelics Virtual Conference: “Clinics and Commercialization: Scaling psychedelics to meet the needs of the mental health space” and “Depression: Spravato opened the door – what comes next?” panels at 12:00pm and 2:00pm ET on September 22, 2021           Cantor Virtual Global Healthcare Conference: fireside chat at 10:40am ET on September 30, 2021Links to these webcasts will be available on the “Events” page of the Investors...

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research & Development and Chief Medical Officer of Intercept, Linda Richardson, Chief Commercial Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 8:40 a.m. ET. A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available...

Philanthropic Fund Expands DTM’s Corporate Giving Activities Company will Reactivate its Employee Volunteer Program DETROIT, Sept. 21, 2021 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) [www.dtmidstream.com], a premier natural gas pipeline, storage and gathering provider, today announced creation of a $2 million charitable fund as part of a wider effort to expand corporate giving activities in places where it does business and to further encourage employee volunteerism. “We’ve got the energy to achieve great things in communities where we live and work,” said David Slater, president and CEO, DT Midstream. “DTM’s charitable giving and volunteerism reinforces our company’s ESG (environmental, social and governance) goals and supports the charitable priorities of our employees and their communities.” DT Midstream will make contributions...

CALABASAS, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, will hold a conference call on Tuesday, September 28, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fiscal fourth quarter and full year ended June 30, 2021. Financial results will be issued in a press release prior to the call. NETSOL management will host the presentation, followed by a question-and-answer period. Date: Tuesday, September 28, 2021Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-Free Dial-In: 877-407-0789International Dial-In: 201-689-8562 Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any...

Patents Further Strengthen and Enhance Intellectual Property (IP) Portfolio CAMBRIDGE, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body, announced today the issuance of two new United States Patents Nos. 11,117,945 and 11,104,712 from the United States Patent and Trademark Office. U.S. Patent No. 11,117,945 covers Cue Biopharma’s first clinical drug candidate, CUE-101, and its use in treating HPV16-associated cancers such as head and neck, cervical, and genitoanal cancers. CUE-101 is currently in a Phase 1b clinical trial in which second line and beyond patients are receiving CUE-101 as a monotherapy for HPV16+ recurrent/metastatic head...

WATERTOWN, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Company’s Management will participate in a fireside chat and one-on-one investor meetings at the Cantor Virtual Global Healthcare Conference to be held September 27-30, 2021. Details on the conference be found below. Cantor Virtual Global Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetingsDate: Monday September 27, 2021Presentation Time: 3:20 p.m. ESTWebcast: Click Here An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com. About Selecta Biosciences, Inc.Selecta...

— Jorge Ruiz, M.D., Associate Director for Clinical Affairs, Geriatric Research at the Miami VA Healthcare System, will present Longeveron’s Aging Frailty Phase 2b Trial Data — National Institute on Aging-funded study showed significant, dose-dependent improvement in walking distance after infusion with Lomecel-B in subjects with mild-to-moderate Aging Frailty MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that Jorge Ruiz, M.D., Associate Director for Clinical Affairs at the Geriatric Research, Education and Clinical Center (GRECC), Miami Veterans Affairs Healthcare System, and lead investigator in...

AUSTIN, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021. Details for the presentation are below:Date: September 29th, 2021Time: 4:40pm ETWebcast https://wsw.com/webcast/cantor12/awh/1906240Management will also be available for virtual 1×1 meetings. To request a meeting, please contact corporateaccess@cantor.com. About ASPIRA Women’s Health Inc.Aspira Women’s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize...

Investview Continues Strong Monthly Results Across Business Divisions: August 2021 Gross Revenue Growth of 223% year-over-year to $9.8 million and Net Income Growth of 823% year-over-year to $3.7 million.Gross Revenue of $9.8 million, up 223% Year-Over-Year August Income from Operations of $3.4 million, up 1,213% Year-Over-Year August Net Revenue of $8.7 million, up 198% Year-Over-Year August Net Income of $3.7 million (includes non-operating income), up $4.3 million or 823% Year-Over-Year August iGenius Subscription and NDAU Gross Revenue of $6.6 million, up 216% Year-Over-Year August iGenius Membership Subscription Record Gross Revenue of $5.4 million, up 155% Year-Over-Year August SAFETek Bitcoin Mining Gross Revenue of $3.1 million, up 238% Year-Over-Year August Bitcoin Mined over 16 months period ending August 2021, 1,072.43 Bitcoin Digital...

BRENTWOOD, Tenn., Sept. 21, 2021 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today that it has entered into a new three-year lease agreement with the State of New Mexico at the Company’s 596-bed Northwest New Mexico Correctional Center. CoreCivic currently operates the Northwest New Mexico Correctional Center under a contract with New Mexico and will transition facility operations to the New Mexico Corrections Department when the new lease agreement commences on November 1, 2021. CoreCivic will retain responsibility for facility maintenance throughout the term of the lease. The new lease agreement includes automatic extension options that could extend the term of the lease through October 31, 2041. Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, said, “We are pleased...